Reproductive Cancers Resource Center: Featured Research

Home » Health Care Providers » Resource Centers » Reproductive Cancers Resource Center » Reproductive Cancers Resource Center: Featured Research

	Reproductive Cancers Resource Center
	This resource center includes information on breast, cervical, prostate, ovarian, endometrial, testicular, vulvar, and uterine cancer, as well as links to organizations dealing with these and other reproductive cancers.

Barton DL et al. Randomized controlled trial to evaluate transdermal testosterone in female cancer survivors with decreased libido; North Central Cancer Treatment Group protocol N02C3. J Natl Cancer Inst. 2007 May 2;99(9):672-9.

Begg CB, Haile RW, Borg A, Malone KE, Concannon P, Thomas DC, et al. Variation of Breast Cancer Risk Among BRAC1/2 Carriers. JAMA. 2008; 299(2):194-201.

Bosch FX, et al. The epidemiology of human papillomavirus infection and cervical cancer. Dis Markers. 2007;23(4):213-27.

Brinton L. Long-term effects of ovulation-stimulating drugs on cancer risk. Reprod Biomed Online. 2007 Jul;15(1):38-44.

Carsten N, Pawinski A, Andratschke NH, Molls M. Does prophylactic breast irradiation in patients with prostate cancer influence cardiac toxicity? JCNI. 2007 Nov 7; 99(21):1646-1647.

Curtis KM, et al. Neoplasia with use of intrauterine devices. Contraception. June 2007 (Vol. 75, Issue 6 (Supplement), Pages S60-S69)

de Cremoux P, et al. No evidence of Human papillomavirus DNA sequences in invasive breast carcinoma. Breast Cancer Res Treat. 2007 Jul 12; [Epub ahead of print]

D’Souza et al. Case-control study of human papillomavirus and oropharyngeal cancer. N Engl J Med. 2007 May 10;356(19):1944-56.

Fackenthal JD, et al. Breast Cancer Risk Associated with BRAC1 and BRAC2 in Diverse Populations. Nature Reviews Cancer. 2007; 7(12): 937-948.

Finley DS et al. Anatomic excision of anterior prostatic fat at radical prostatectomy: Implications for pathologic upstating. Urology. 2007 Nov; 70(5):1000-1003.

Glass AG, et al. Breast cancer incidence, 1980-2006: combined roles of menopausal hormone therapy, screening mammography, and estrogen receptor status. J Natl Cancer Inst. 2007 Aug 1;99(15):1152-61.

Gomez BP, et al. Human X-Box binding protein-1 confers both estrogen independence and antiestrogen resistance in breast cancer cell lines. The FASEB Journal. Published online before print July 27, 2007.

Green J, et al. Cervical cancer and hormonal contraceptives: collaborative reanalysis of individual data for 16,573 women with cervical cancer and 35,509 women without cervical cancer from 24 epidemiological studies. The Lancet. 10 Nov 2007; 370:1609-1621.

Hall SA, et al. Do statins affect androgen levels in men? Results from the Boston area community health survey. Cancer Epidemiol Biomarkers Prev. 2007 Aug;16(8):1587-94.

Hampel H, et al. Screening for Lynch syndrome (hereditary nonpolyposis colorectal cancer) among endometrial cancer patients. Cancer Res. 2006 Aug 1;66(15):7810-7.

Heiss G, Wallace R, Anderson GL et al. Health Risks and Benefits 3 Years After Stopping Randomized Treatment With Estrogen and Progestin. JAMA. 2008;299(9):1036-1045.

Jemal A, Ward E and Thun MJ. Recent trends in breast cancer incidence rates by age and tumor characteristics among U.S. women. Breast Cancer Research 2007, 9:R28, doi:10.1186/bcr1672.

Jeronimo J, et al. Visual appearance of the uterine cervix: correlation with human papillomavirus detection and type. American Journal of Obstetrics and Gynecology. July 2007 (Vol. 197, Issue 1, Pages 47.e1-47.e8)

Jørgensen KT, Pedersen BV, Johansen C, Frisch M. Fatherhood status and prostate cancer risk. Cancer. 2008 Jan 7; [Epub ahead of print].

Kuhl CK, et al. MRI for diagnosis of pure ductal carcinoma in situ: a prospective observational study. The Lancet. 2007; 370:485-492. (free registration required)

Lambert S, et al. Infertility and Testis Cancer. Urol Clin North Am. 2007 May;34(2):269-77.

Mayrand MH et al. Human papillomavirus DNA versus Papanicolaou screening tests for cervical cancer. N Engl J Med. 2007 Oct 18;357(16):1579-88.

Meirow D, Hardan I, Dor J, et al. Searching for evidence of disease and malignant cell contamination in ovarian tissue stored from hematologic cancer patients. Hum Reprod; 2008 Mar 15.

Mitwally MF. Effect of cancer and cancer treatment on human reproduction. Expert Rev Anticancer Ther. 2007 Jun;7(6):811-22.

Moscicki AB. HPV infections in adolescents. Dis Markers. 2007;23(4):229-34.

Naucler P et al. Human papillomavirus and Papanicolaou tests to screen for cervical cancer. N Engl J Med. 2007 Oct 18;357(16):1589-97.

Oldenburg RA, et al. Genetic susceptibility for breast cancer: How many more genes to be found? Critical Reviews in Oncology and Hematology. August 2007 (Vol. 63, Issue 2, Pages 125-149).

Palefsky JM. HPV infection in men. Dis Markers. 2007;23(4):261-72.

Park JW, et al. Treatment With Autologous Antigen-Presenting Cells Activated With the HER-2 Based Antigen Lapuleucel-T: Results of a Phase I Study in Immunologic and Clinical Activity in HER-2 Overexpressing Breast Cancer. J Clin Oncol. 2007 Aug 20;25(24):3680-7.

Prentice RL et al. Low-Fat Dietary Pattern and Cancer Incidence in the Women’s Health Initiative Dietary Modification Randomized Controlled Trial. J Natl Cancer Inst 2007. Epub ahead of print.

Rajapaksa RC, Macari M, Bini EJ. Racial/ethnic differences in patient experiences with and preferences for computed tomography colonography and optical colonoscopy. Clin Gastroeterol Hepatol. 2007 Aug 3; [Epub ahead of print].

Robbins C et al. Confirmation study of prostate cancer risk variants at 8q24 in African Americans identifies a novel risk locus. Genome Research. 2007 Oct 31; [Epub ahead of print].

Sankaranarayanan R, et al. Effect of visual screening on cervical cancer incidence and mortality in Tamil Nadu, India: a cluster-randomised trial. The Lancet 2007; 370:398-406. (free registration required)

Simcock B, et al. Invasive cancer of the cervix. Obstetrics, Gynaecology & Reproductive Medicine. June 2007 (Vol. 17, Issue 6, Pages 181-187).

Stead ML, et al. Psychosexual function and impact of gynaecological cancer. Best Practice & Research Clinical Obstetrics & Gynaecology. April 2007 (Vol. 21, Issue 2, Pages 309-320).

Strander B, Andersson-Ellström A, Milsom I, et al. Long term risk of invasive cancer after treatment for cervical intraepithelial neoplasia grade 3: population based cohort study. BMJ. 2007 Oct 24.

Tomlins SA, et al. Distinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancer. Nature. 2007 Aug 2;448(7153):595-9.

Tworoger SS, et al. Association of Oral Contraceptive Use, Other Contraceptive Methods, and Infertility with Ovarian Cancer Risk. Am J Epidemiol. 2007 Jul 26; [Epub ahead of print]

Van Howe RS. Human papillomavirus and circumcision: A meta-analysis. Journal of Infection. May 2007 (Vol. 54, Issue 5, Pages 490-496).

Van Seters M et al. Treatment of Vulvar Intraepithelial Neoplasia with Topical Imiquimod. New England Journal of Medicine. 2008 Apr 3; 358(14): 1465-73.

Vessey M, Painter R. Oral contraceptive use and cancer. Findings in a large cohort study, 1968-2004. Br J Cancer. 2006 Aug 7;95(3):385-9. Epub 2006 Jul 4.

Wentzensen N, et al. Biomarkers in cervical cancer screening. Dis Markers. 2007;23(4):315-30.

CA: A Cancer Journal for Clinicians (free, full-text articles online)

Gynecologic Oncology

International Journal of Gynecological Cancer

The Journal of Reproductive Medicine

Terms And Conditions